Recombinant Mouse Claudin-1 (Cldn1)

What is the full amino acid sequence of Mouse Claudin-1?

Mouse Claudin-1 consists of 211 amino acids with a sequence highly homologous to human Claudin-1. The human sequence is: MANAGLQLLGFILAFLGWIGAIVSTALPQWRIYSYAGDNIVTAQAMYEGLWMSCVSQSTGQIQCKVFDSLLNLSSTLQATRALMVVGILLGVIAIFVATVGMKCMKCLEDDEVQKMRMAVIGGAIFLLAGLAILVATAWYGNRIVQEFYDPMTPVNARYEFGQALFTGWAAASLCLLGGALLCCSCPRKTSYPTPRPYPKPAPSSGKDYV . Mouse Claudin-1 shares approximately 90% sequence identity with human Claudin-1, with most variations occurring in the C-terminal cytoplasmic domain.

What are the primary functions of Claudin-1 in biological systems?

Claudin-1 functions as a major constituent of tight junction complexes that regulate epithelial permeability. It plays essential roles in:

• Preventing paracellular diffusion of small molecules through tight junctions in the epidermis

• Maintaining normal barrier function of the skin

• Regulating water homeostasis and preventing excessive water loss through the skin

• Contributing to the selective ion permeability of various epithelial tissues

Unlike some claudin family members that form permeable barriers, Claudin-1 primarily contributes to impermeable barrier formation, although its specific function may vary depending on which other claudins it is co-expressed with in a given tissue .

What expression systems are most effective for producing recombinant Mouse Claudin-1?

Several expression systems have been successfully used for recombinant Claudin-1 production:

• Yeast expression (P. pastoris): Provides high yields and proper protein folding. This system has been demonstrated to produce correctly folded, antigenic Claudin-1 that forms oligomeric structures similar to those observed in mammalian cells .

• Wheat germ cell-free expression system: Effective for producing full-length Claudin-1 (amino acids 1-211) suitable for applications such as ELISA and Western blotting .

• Mammalian expression systems: While not detailed in the provided search results, these systems can provide native-like post-translational modifications but typically with lower yields than yeast systems.

The choice depends on your downstream applications, with yeast systems offering a good balance between yield and proper folding for structural and functional studies .

What are the optimal detergents for extraction and purification of Claudin-1?

The choice of detergent significantly impacts the oligomeric state and functionality of extracted Claudin-1:

For biophysical characterization requiring monodispersed samples, βOG extraction followed by nickel-affinity chromatography and size exclusion chromatography is recommended .

How can the oligomeric state of recombinant Claudin-1 be determined?

The oligomeric state of Claudin-1 can be analyzed using several complementary approaches:

• Analytical ultracentrifugation (AUC): Provides definitive data on the size distribution and oligomeric state of purified Claudin-1 in detergent solutions. This has revealed that βOG extraction yields monodispersed dimers while other detergents produce dynamic mixtures of oligomers .

• SDS-PAGE under non-reducing conditions: Can reveal the presence of higher-order oligomers that are stabilized by disulfide bonds .

• Dynamic light scattering (DLS): Useful for analyzing the hydrodynamic radius of Claudin-1 oligomers and monitoring complex formation with interacting partners such as CD81 .

• Native PAGE: Although not explicitly mentioned in the search results, this technique can provide information about non-covalent oligomeric assemblies.

For comprehensive characterization, a combination of these methods is recommended to overcome the limitations of any single approach.

How does Claudin-1 interact with other tight junction proteins and viral receptors?

Claudin-1 forms specific protein-protein interactions that are critical for its biological functions:

• Interaction with CD81: Recombinant Claudin-1 associates with CD81 in vitro in a defined molar ratio of 1:2 (Claudin-1:CD81). This interaction occurs in the absence of other cellular components and is enhanced by cholesteryl hemisuccinate, consistent with reports that cholesterol promotes complex formation in mammalian cells .

• Claudin-1/CD81 complex: Forms a receptor complex essential for hepatitis C virus (HCV) entry into hepatocytes. Dynamic preparations of Claudin-1 (in foscholine-10) can associate with CD81, while monodispersed Claudin-1 (in βOG) fails to form this complex .

• Viral receptor function: While human Claudin-1 serves as a co-receptor for HCV and a receptor for dengue virus, mouse Claudin-1 may have different binding affinities for these pathogens due to sequence variations .

To study these interactions, researchers can use purified proteins in detergent micelles or reconstituted proteoliposomes, although the latter may be challenging as Claudin-1 incorporation can render proteoliposomes intractable to study .

What are the validated applications for antibodies against Mouse Claudin-1?

Antibodies against Claudin-1 have been validated for multiple applications:

• Western Blotting (WB): For detecting Claudin-1 in protein extracts and assessing expression levels .

• Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative detection of Claudin-1 .

• Immunohistochemistry (IHC): Particularly in paraffin-embedded sections (IHC-P), allowing visualization of Claudin-1 localization in tissues .

• Immunoprecipitation (IP): For isolating Claudin-1 and its binding partners .

• Immunofluorescence (IF): For subcellular localization studies, though this was not explicitly mentioned for mouse Claudin-1 in the search results.

When selecting antibodies, consider whether they recognize conformational epitopes (for native protein studies) or linear epitopes (better for denatured protein detection) .

What methods can verify the correct folding of recombinant Claudin-1?

Verifying correct folding is crucial for functional studies. Several approaches include:

• Conformation-dependent antibody binding: Antibodies that recognize native epitopes can be used in flow cytometry or confocal imaging to confirm proper folding. Studies have shown specific binding of such antibodies to yeast-expressed Claudin-1 .

• Circular dichroism (CD) spectroscopy: Though not mentioned in the search results, this technique can assess secondary structure content.

• Functional binding assays: While recombinant Claudin-1 does not directly bind soluble HCV E2 glycoprotein (sE2), its ability to form specific complexes with CD81 indicates correct folding .

• Oligomerization analysis: Properly folded Claudin-1 forms specific oligomeric states that can be detected by analytical techniques as discussed in section 3.1 .

These complementary approaches provide different insights into protein structure and should be selected based on your specific research questions.

How can recombinant Claudin-1 be used for structural biology studies?

Structural analysis of Claudin-1 presents several challenges and opportunities:

• Protein production: Expressing Claudin-1 in yeast (P. pastoris) followed by extraction with appropriate detergents provides material suitable for structural studies .

• Protein stabilization: The dynamic nature of Claudin-1 oligomers presents challenges for crystallization. Monodispersed preparations (in βOG) may be more amenable to crystallization attempts, while dynamic preparations better represent physiological states .

• Complex formation: The ability to form defined complexes with CD81 (1:2 ratio) in vitro opens possibilities for structural studies of the receptor complex relevant to HCV entry .

• Reconstitution systems: While challenging due to the effects of Claudin-1 on liposome properties, reconstitution into nanodiscs or other membrane mimetics may provide platforms for structural analysis .

The first in-depth characterization of recombinant, full-length Claudin-1 has paved the way for structural analysis of the claudin superfamily and structure-aided design of therapeutic agents targeting processes such as HCV entry .

What factors influence Claudin-1 oligomerization and how can researchers control this process?

Claudin-1 oligomerization is influenced by multiple factors that researchers can manipulate:

• Detergent selection: Different detergents yield different oligomeric states - βOG produces dimers while foscholine-10 and other detergents yield dynamic mixtures of oligomers .

• Cholesterol content: Claudin-1 complexes are stabilized by cholesteryl hemisuccinate, indicating that membrane cholesterol content significantly influences oligomerization and protein-protein interactions .

• Reducing conditions: Non-reducing SDS-PAGE reveals diverse oligomeric states compared to reducing conditions, suggesting disulfide bonds may stabilize some oligomeric forms .

• Membrane environment: Reconstitution into liposomes with defined lipid composition can influence oligomerization, although working with Claudin-1-containing proteoliposomes presents technical challenges .

• Protein concentration: Though not explicitly mentioned in the search results, protein concentration typically influences oligomerization equilibria.

Understanding these factors allows researchers to design experiments with appropriate controls for the desired oligomeric state of Claudin-1.

How does Mouse Claudin-1 differ from Human Claudin-1 in disease models?

While the search results focus primarily on human Claudin-1, important differences between mouse and human Claudin-1 affect their use in disease models:

• Viral receptor function: Human Claudin-1 serves as a co-receptor for HCV and associates with CD81 to facilitate viral entry, but mouse Claudin-1 may have different binding affinities for viral proteins due to sequence variations .

• Species-specific interactions: The interaction between Claudin-1 and other tight junction proteins may vary between species, affecting the interpretation of mouse models for human diseases.

• Tissue-specific expression patterns: While many expression patterns are conserved, subtle differences in tissue-specific expression or regulation between mouse and human Claudin-1 may impact disease modeling.

Researchers should consider these differences when translating findings between mouse models and human disease, particularly for infectious disease studies involving HCV or dengue virus .

What is the potential of Claudin-1-targeted nanoparticles for drug delivery?

Claudin-1-targeted nanoparticles represent an emerging approach for targeted drug delivery:

• Targeting specificity: Claudin-1's expression in tight junctions of specific epithelia makes it a potential target for delivering drugs to these barriers .

• Barrier penetration: Targeting Claudin-1 may facilitate drug delivery across otherwise impermeable epithelial barriers .

• Disease-specific applications: Altered Claudin-1 expression in certain disease states (such as inflammatory conditions or cancers) offers opportunities for targeted therapies .

While the search results contain limited information on this topic (with result being cut off), the development of Claudin-1-targeted nanoparticles highlights the potential therapeutic applications of understanding Claudin-1 biology and interactions.